[Skip to Content]
[Skip to Content Landing]
Article
August 1982

Valproic AcidTreatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica

Author Affiliations

From the Department of Medicine (Neurology), Duke University Medical Center, Durham, NC.

Arch Neurol. 1982;39(8):527-528. doi:10.1001/archneur.1982.00510200069016
Abstract

• Valproic acid produced marked reduction in myoclonus in a patient with dyssynergia cerebellaris myoclonica (DCM), resulting in substantial functional improvement. These results justify a trial of valproic acid in patients with DCM who are disabled by myoclonus.

×